AKRX(.20) -Akorn Pharma- 650+million revenues, restructure and lending agreements to be made could see 5X Fold gains ahead. Has up to $5 billion in potential annualized revenue with their current Anda pipeline Agreements can be made prior to May 01
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.